Discovery of Clinical Candidate NTQ1062 as a Potent and Bioavailable Akt Inhibitor for the Treatment of Human Tumors.
Ma C, Wu J, Wang L, Ji X, Wu Y, Miao L, Chen D, Zhang L, Wu Y, Feng H, Tang Y, Zhou Q, Pei J, Yang X, Xu D, You Q, Xie Y.
Ma C, et al. Among authors: you q.
J Med Chem. 2022 Jun 23;65(12):8144-8168. doi: 10.1021/acs.jmedchem.2c00527. Epub 2022 Jun 9.
J Med Chem. 2022.
PMID: 35679512